Several pharmacogenetic variants showed distinct allele frequencies in the Bulgarian cohort and highlight the value of locally derived pharmacogenetic data for precision oncology and pharmacogenetically guided treatment strategies.
Abstract
Background/Objectives: Pharmacogenetic variability influences the efficacy and toxicity of anticancer therapies. However, Eastern European populations remain underrepresented in pharmacogenetic databases. This study aimed to characterize pharmacogenetic variants relevant to chemotherapy response in the Bulgarian population and compare their allele frequencies with reference populations. Methods: Ninety individuals were included, comprising 50 patients with colorectal, non-small cell lung, or breast cancer and 40 healthy controls. Genomic DNA and circulating cell-free DNA were analyzed by next-generation sequencing targeting pharmacogenetic genes involved in drug metabolism, transport, and DNA repair. Allele frequencies were compared with gnomAD v2.1.1 reference data. Sensitivity analyses compared Bulgarian controls with Bulgarian non-cancer and combined Southern European, Northwestern European, and Other non-Finnish European non-cancer populations. Results: Twenty-three pharmacogenetic variants were evaluated. Six variants remained statistically significant after Benjamini–Hochberg correction in both Fisher’s exact test and the two-proportion Z-test. Five variants—DPYD c.2194G>A, XPC c.2815C>A, EGFR c.1562G>A, XRCC1 c.1196A>G, and ERCC2 c.2251A>C—showed higher allele frequencies, whereas ERCC2 c.934G>A was less frequent in the Bulgarian cohort. DPYD c.85T>C remained significant after correction in the Z-test but not in Fisher’s exact test. Sensitivity analyses confirmed the significance of XPC c.2815C>A in both reference-population comparisons, while DPYD c.85T>C remained significant only against the combined European reference population. Conclusions: Several pharmacogenetic variants showed distinct allele frequencies in the Bulgarian cohort. XPC c.2815C>A demonstrated the most robust population-specific pattern across sensitivity analyses. These findings highlight the value of locally derived pharmacogenetic data for precision oncology and pharmacogenetically guided treatment strategies.
The frequency and distribution of common, clinically relevant, and rare DPYD variants in a Russian cohort of patients receiving fluoropyrimidine-containing chemotherapy and the observed allele frequencies with European and East Asian reference populations are compared.
D. Fedorinov, V. Lyadov, M. Lyadova et al.· Genes· 0 citations
Background: Pharmacogenomic variation contributes to interindividual differences in drug response, yet population-specific pharmacogenomic profiles remain insufficiently characterized in the Western Balkans (WB). This study aimed to comprehensively characterize pharmacogenomic variability in the WB populations using wh...
Vietnamese pharmacogenomic frequencies are regionally East Asian-adjacent but not interchangeable with a generic East Asian reference and implementation should combine local frequency evidence with guideline strength, preventable clinical harm, medication use, and assay complexity, while preserving haplotype and struct...
Van Thi Bich Hoang, Anh Van Tran, Tham Thi Bui et al.· Frontiers in Pharmacology· 0 citations
Amazonian Indigenous populations exhibit substantial pharmacogenomic diversity in genes relevant to Berlin-Frankfurt-Münster-based therapy and these findings identify candidate variants for functional and clinical validation and reinforce the importance of including underrepresented populations in pharmacogenomic resea...
L. P. C. Leitão, Natasha Monte, Juliana Carla Rodrigues Marcellino et al.· Clinical and Translational O...· 0 citations
The findings highlight the limited representation of admixed populations in pharmacogenetic research and underscore the need for population-specific data to inform safe and equitable fluoropyrimidine dosing.
Vanessa González-Covarrubias, Andrea Morales-Alfaro, Oscar Bonilla-Jimenez et al.· Cancer Chemotherapy and Phar...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.